4//SEC Filing
YAO TONY DUNG LING 4
Accession 0001209191-19-022659
CIK 0001357874other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 5:19 PM ET
Size
20.9 KB
Accession
0001209191-19-022659
Insider Transaction Report
Form 4
YAO TONY DUNG LING
Director
Transactions
- Conversion
Common Stock
2019-04-01$13.60/sh+36,946$502,466→ 36,946 total(indirect: By ArrowMark Life Science Fund, LP) - Conversion
Series B Preferred Stock
2019-04-01−244,572→ 0 total(indirect: By ArrowMark Life Science Fund, LP)→ Common Stock (114,570 underlying) - Conversion
Common Stock
2019-04-01+4,450→ 4,450 total(indirect: By LLC) - Conversion
Series B Preferred Stock
2019-04-01−9,500→ 0 total→ Common Stock (4,450 underlying) - Conversion
Convertible Promissory Note
2019-04-01→ 0 total(indirect: By ArrowMark Life Science Fund, LP)Exercise: $13.60→ Common Stock (36,946 underlying) - Conversion
Series B Preferred Stock
2019-04-01−9,500→ 0 total(indirect: By LLC)→ Common Stock (4,450 underlying) - Conversion
Common Stock
2019-04-01+4,450→ 4,450 total - Conversion
Common Stock
2019-04-01+114,570→ 151,516 total(indirect: By ArrowMark Life Science Fund, LP)
Footnotes (4)
- [F1]The Series B Preferred Stock automatically converted into the common stock of Precision BioSciences, Inc. (the "Issuer") on a 2.134686-to-1 basis (after giving effect to the Issuer's previously completed reverse stock split) upon the closing of the Issuer's initial public offering (the "IPO").
- [F2]These securities are held of record by the ArrowMark Life Science Fund, LP (the "ArrowMark Fund"). ArrowMark Colorado Holdings LLC ("ArrowMark Colorado") is an investment advisor to the ArrowMark Fund. The reporting person is employed as a portfolio manager for ArrowMark Colorado and has direct voting and dispositive control over the shares held by the ArrowMark Fund. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F3]These securities are held of record by the THB Iron Rose, LLC Life Science Portfolio (the "THB Fund"). ArrowMark Colorado is an investment advisor to the THB Fund. The reporting person is employed as a portfolio manager for ArrowMark Colorado and has direct voting and dispositive control over the shares held by the THB Fund. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F4]On March 1, 2019, the ArrowMark Fund acquired a convertible promissory note in the principal amount of $500,000 (the "2019 Note") from the Issuer. Effective upon the closing of the IPO on April 1, 2019, the 2019 Note, including accrued interest, converted into 36,946 shares of the Issuer's common stock at a price per share equal to $13.60, which represented 85% of the price per share in the IPO.
Documents
Issuer
PRECISION BIOSCIENCES INC
CIK 0001357874
Entity typeother
Related Parties
1- filerCIK 0001771680
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 5:19 PM ET
- Size
- 20.9 KB